Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$20.95
-1.4%
$20.26
$13.40
$25.23
$3.51B0.641.98 million shs916,956 shs
Docusign Inc. stock logo
DOCU
Docusign
$78.97
+2.4%
$82.20
$48.80
$107.86
$15.97B1.082.87 million shs1.92 million shs
Lennar Corporation stock logo
LEN
Lennar
$110.35
-4.3%
$108.89
$98.42
$187.61
$29.05B1.332.72 million shs3.16 million shs
The ODP Corporation stock logo
ODP
ODP
$18.90
-5.1%
$16.90
$11.85
$43.31
$591.41M1.34600,268 shs173,622 shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
0.00%-5.29%-1.83%+36.22%+34.38%
Docusign Inc. stock logo
DOCU
Docusign
0.00%+3.26%-15.00%+9.36%+45.88%
Lennar Corporation stock logo
LEN
Lennar
0.00%+0.01%+0.34%-0.47%-23.05%
The ODP Corporation stock logo
ODP
ODP
0.00%+5.56%+4.97%+36.23%-52.30%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
4.6238 of 5 stars
4.43.00.00.02.54.22.5
Docusign Inc. stock logo
DOCU
Docusign
4.7228 of 5 stars
3.13.00.03.53.22.52.5
Lennar Corporation stock logo
LEN
Lennar
4.824 of 5 stars
3.13.02.52.32.91.73.1
The ODP Corporation stock logo
ODP
ODP
4.5686 of 5 stars
3.03.00.02.51.31.73.8
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
2.71
Moderate Buy$27.8833.05% Upside
Docusign Inc. stock logo
DOCU
Docusign
2.25
Hold$89.7713.68% Upside
Lennar Corporation stock logo
LEN
Lennar
2.24
Hold$128.8516.76% Upside
The ODP Corporation stock logo
ODP
ODP
2.00
Hold$28.0048.19% Upside

Current Analyst Ratings Breakdown

Latest LEN, ACAD, DOCU, and ODP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/26/2025
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform$19.00 ➝ $22.00
6/26/2025
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$37.00
6/26/2025
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$30.00
6/26/2025
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$32.00
6/23/2025
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$26.00 ➝ $38.00
6/20/2025
Lennar Corporation stock logo
LEN
Lennar
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Perform ➝ Market Perform$128.00 ➝ $114.00
6/20/2025
Lennar Corporation stock logo
LEN
Lennar
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$150.00 ➝ $130.00
6/18/2025
Lennar Corporation stock logo
LEN
Lennar
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$131.00 ➝ $114.00
6/18/2025
Lennar Corporation stock logo
LEN
Lennar
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$130.00
6/18/2025
Lennar Corporation stock logo
LEN
Lennar
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$110.00 ➝ $105.00
6/18/2025
Lennar Corporation stock logo
LEN
Lennar
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$122.00 ➝ $98.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$996.28M3.52$0.70 per share29.72$4.40 per share4.76
Docusign Inc. stock logo
DOCU
Docusign
$3.03B5.26$2.92 per share27.01$9.97 per share7.92
Lennar Corporation stock logo
LEN
Lennar
$35.37B0.82$14.67 per share7.52$86.17 per share1.28
The ODP Corporation stock logo
ODP
ODP
$6.99B0.08$6.80 per share2.78$26.79 per share0.71
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$226.45M$1.3715.2927.574.5122.97%17.46%10.75%8/5/2025 (Estimated)
Docusign Inc. stock logo
DOCU
Docusign
$1.07B$5.2914.9359.8229.4936.50%14.27%7.34%9/4/2025 (Estimated)
Lennar Corporation stock logo
LEN
Lennar
$3.93B$12.099.137.104.549.20%12.73%8.57%9/18/2025 (Estimated)
The ODP Corporation stock logo
ODP
ODP
-$3M-$1.39N/A4.330.46-0.69%11.50%2.68%8/6/2025 (Estimated)

Latest LEN, ACAD, DOCU, and ODP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/16/2025Q2 2025
Lennar Corporation stock logo
LEN
Lennar
$1.94$1.90-$0.04$1.81$8.21 billion$8.38 billion
6/5/2025Q1 2026
Docusign Inc. stock logo
DOCU
Docusign
$0.81$0.90+$0.09$0.34$748.79 million$763.65 million
5/7/2025Q1 2025
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$0.10$0.11+$0.01$0.11$239.32 million$244.32 million
5/7/2025Q1 2025
The ODP Corporation stock logo
ODP
ODP
$0.65$1.06+$0.41-$0.97$1.67 billion$1.70 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
N/AN/AN/AN/AN/A
Docusign Inc. stock logo
DOCU
Docusign
N/AN/AN/AN/AN/A
Lennar Corporation stock logo
LEN
Lennar
$2.001.81%N/A16.54%1 Years
The ODP Corporation stock logo
ODP
ODP
N/AN/AN/AN/AN/A

Latest LEN, ACAD, DOCU, and ODP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/20/2025
Lennar Corporation stock logo
LEN
Lennar
quarterly$0.501.9%7/3/20257/3/20257/18/2025
4/10/2025
Lennar Corporation stock logo
LEN
Lennar
quarterly$0.501.9%4/23/20254/23/20255/7/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
N/A
2.88
2.80
Docusign Inc. stock logo
DOCU
Docusign
N/A
0.79
0.79
Lennar Corporation stock logo
LEN
Lennar
0.12
3.65
0.49
The ODP Corporation stock logo
ODP
ODP
0.32
0.94
0.45

Institutional Ownership

CompanyInstitutional Ownership
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
96.71%
Docusign Inc. stock logo
DOCU
Docusign
77.64%
Lennar Corporation stock logo
LEN
Lennar
81.10%
The ODP Corporation stock logo
ODP
ODP
99.56%

Insider Ownership

CompanyInsider Ownership
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
26.50%
Docusign Inc. stock logo
DOCU
Docusign
1.01%
Lennar Corporation stock logo
LEN
Lennar
10.00%
The ODP Corporation stock logo
ODP
ODP
3.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
510167.36 million123.01 millionOptionable
Docusign Inc. stock logo
DOCU
Docusign
6,838202.06 million200.02 millionOptionable
Lennar Corporation stock logo
LEN
Lennar
13,265263.79 million237.42 millionOptionable
The ODP Corporation stock logo
ODP
ODP
19,00030.08 million29.00 millionOptionable

Recent News About These Companies

ODP Corp. SEC Filings - MarketWatch
ODP (NASDAQ:ODP) Shares Down 5.1% - Time to Sell?
The ODP Corp Executives - Morningstar
Best Growth Stocks to Buy for June 24th
ODP (NASDAQ:ODP) Upgraded at Wall Street Zen
ODP (NASDAQ:ODP) Trading Down 5.2% - Here's Why

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
ACADIA Pharmaceuticals stock logo

ACADIA Pharmaceuticals NASDAQ:ACAD

$20.95 -0.29 (-1.37%)
Closing price 07/3/2025 03:39 PM Eastern
Extended Trading
$20.95 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome. It also develops Pimavanserin that is in Phase III ADVANCE-2 study to treat the negative symptoms of schizophrenia; ACP-101 whixh is in Phase III for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 which is in Phase II for the treatment of Alzheimer's disease psychosis; ACP-2591 that is in Phase I for Rett syndrome and Fragile X syndrome; preclinical antisense oligonucleotide programs; and other programs for neuropsychiatric symptoms. It has a license agreement with Neuren Pharmaceuticals Limited to develop and commercialize trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.

Docusign stock logo

Docusign NASDAQ:DOCU

$78.97 +1.82 (+2.35%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$79.02 +0.05 (+0.06%)
As of 07/3/2025 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DocuSign, Inc. provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce. It also provides Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; Monitor that uses advanced analytics to track DocuSign eSignature web, mobile, and API account; Notary which enables notaries public to conduct remote online notarization transactions; and Web Forms, a web forms that quickly draft agreements using pre-populated data from completed forms or external systems via APIs. In addition, the company offers Rooms for Real Estate that provides a way for brokers and agents to manage the entire real estate transaction digitally. Signature and CLM are FedRAMP, an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct and partner-assisted sales, and digital self-service purchasing. DocuSign, Inc. was incorporated in 2003 and is headquartered in San Francisco, California.

Lennar stock logo

Lennar NYSE:LEN

$110.35 -4.96 (-4.30%)
Closing price 07/3/2025 03:51 PM Eastern
Extended Trading
$110.23 -0.12 (-0.11%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lennar Corporation, together with its subsidiaries, operates as a homebuilder primarily under the Lennar brand in the United States. It operates through Homebuilding East, Homebuilding Central, Homebuilding Texas, Homebuilding West, Financial Services, Multifamily, and Lennar Other segments. The company's homebuilding operations include the construction and sale of single-family attached and detached homes, as well as the purchase, development, and sale of residential land; and development, construction, and management of multifamily rental properties. It also offers residential mortgage financing, title, insurance, and closing services for home buyers and others, as well as originates and sells securitization commercial mortgage loans. In addition, the company is involved in the fund investment activity. It primarily serves first-time, move-up, active adult, and luxury homebuyers. Lennar Corporation was founded in 1954 and is based in Miami, Florida.

ODP stock logo

ODP NASDAQ:ODP

$18.90 -1.01 (-5.05%)
Closing price 07/3/2025 01:24 PM Eastern
Extended Trading
$19.64 +0.75 (+3.97%)
As of 07/3/2025 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The ODP Corporation provides business services and supplies, products, and digital workplace technology solutions for small, medium, and enterprise businesses in the United States, Puerto Rico, and the U.S. Virgin Islands. The company operates through four divisions: ODP Business Solutions, Office Depot, Veyer, and Varis. The ODP Business Solutions division offers adjacency products, including cleaning, janitorial, and breakroom supplies, office furniture, technology products; and copy and print services through sales force, catalogs, telesales, and through Internet websites. This segment also engages in office supply distribution business. The Office Depot division sells office supplies, technology products and solutions, business machines and related supplies, cleaning, breakroom and facilities products, personal protective equipment, and office furniture; and offers business services, including copying, printing, digital imaging, mailing, shipping, and technology support services through a fully integrated omni-channel platform of 980 Office Depot and OfficeMax retail stores, and through www.officedepot.com. The Veyer division engages in supply chain, distribution, procurement, and global sourcing operations. The Varis division operates tech-enabled B2B indirect procurement marketplace, where buyers and suppliers to transact through the platform's consumer-like buying experience, advanced spend management tools, network of suppliers, and technology capabilities. The company offers its products under various brands, including Office Depot, OfficeMax, and Grand&Toy, as well as others. The ODP Corporation was incorporated in 1986 and is headquartered in Boca Raton, Florida.